Carmichael Hill & Associates’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $147 | Hold |
100
| – | – | ﹤0.01% | 652 |
|
|
2024
Q2 | $135 | Hold |
100
| – | – | ﹤0.01% | 665 |
|
|
2024
Q1 | $164 | Hold |
100
| – | – | ﹤0.01% | 659 |
|
|
2023
Q4 | $193 | Hold |
100
| – | – | ﹤0.01% | 666 |
|
|
2023
Q3 | $240 | Hold |
100
| – | – | ﹤0.01% | 659 |
|
|
2023
Q2 | $255 | Hold |
100
| – | – | ﹤0.01% | 664 |
|
|
2023
Q1 | $163 | Hold |
100
| – | – | ﹤0.01% | 666 |
|
|
2022
Q4 | $274 | Hold |
100
| – | – | ﹤0.01% | 647 |
|
|
2022
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 782 |
|
|
2022
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 682 |
|
|
2022
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 665 |
|
|
2021
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 667 |
|
|
2021
Q3 | $3K | Hold |
100
| – | – | ﹤0.01% | 618 |
|
|
2021
Q2 | $5K | Hold |
100
| – | – | ﹤0.01% | 566 |
|
|
2021
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 534 |
|
|
2020
Q4 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 540 |
|